Arcturus Therapeutics Holdings Inc. (ARCT)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Arcturus Therapeutics Holdings Inc. reported revenue of $82.03M, down 46.1% from the prior year. The company ran a net loss, with a net margin of -80.2%. It held $271.15M in total assets against $57.16M in total liabilities.
Key ratios (FY2025)
-93.0%
Operating margin
-80.2%
Net margin
-30.7%
Return on equity
-46.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $82.03M | $152.31M | $166.80M | $206.00M | $12.36M | $9.54M | $20.79M | $15.75M | — |
| Operating Income | -$76.26M | -$95.67M | -$78.20M | $12.18M | -$202.85M | -$71.52M | -$25.51M | -$21.81M | — |
| Net Income | -$65.78M | -$80.94M | -$29.73M | $9.35M | -$203.67M | -$72.15M | -$25.99M | -$21.79M | — |
| EPS (Diluted) | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 | — | — | — | — |
| Total Assets | $271.15M | $344.07M | $429.40M | $450.39M | $392.81M | $476.46M | $82.14M | $44.20M | — |
| Total Liabilities | $57.16M | $103.09M | $150.89M | $180.07M | $164.60M | $79.90M | $56.35M | $30.56M | — |
| Shareholders' Equity | $213.99M | $240.98M | $278.51M | $270.31M | $228.21M | $396.55M | $25.79M | $13.64M | $33.79M |
| Cash & Equivalents | $230.91M | $237.03M | $292.00M | $391.88M | $370.49M | $462.89M | $71.35M | $36.71M | — |
| Operating Cash Flow | -$74.27M | -$59.75M | -$18.10M | $31.99M | -$135.04M | -$42.86M | -$6.45M | -$20.76M | — |
| Capital Expenditures | $230.0K | $648.0K | $2.90M | $7.73M | $3.41M | $1.74M | $818.0K | $1.48M | — |
| Shares Outstanding | 28.41M | 27.00M | 26.83M | 26.55M | 26.37M | 26.19M | 15.14M | 10.72M | — |